ArticleInternational journal of molecular sciences2023

Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.

David Vicente-Zurdo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.